Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAZAZ: Personalized Antibiotics in Pediatric Crohn's Disease
NCT04186247Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of azithromycin, metronidazole in Crohn's disease, sponsored by University of North Carolina at Chapel Hill. Started Aug 2021; status: terminated.
02
Drugs
azithromycinmetronidazole
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04186247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186247.